Fluticasone Furoate (27.5 mcg) + Oxymetazoline (50 mcg) Nasal Spray | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare



Fluticasone Furoate (27.5 mcg) + Oxymetazoline (50 mcg) Nasal Spray — manufactured by Trumac Healthcare

Fluticasone Furoate (27.5 mcg) + Oxymetazoline (50 mcg) Nasal Spray

WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India

Salt: Fluticasone Furoate (27.5 mcg) + Oxymetazoline (50 mcg)
Form: Nasal Spray
Class: Intranasal corticosteroid + alpha-adrenergic decongestant
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ 1 Brand Options

Pricing, brochure & monopoly territory within 24 hrs.

Our Fluticasone Furoate (27.5 mcg) + Oxymetazoline (50 mcg) Nasal Spray Brand Options (1 option)

Trumac Healthcare manufactures and supplies the following Fluticasone Furoate (27.5 mcg) + Oxymetazoline (50 mcg) Nasal Spray brands for PCD pharma distribution. Click any brand to view full specifications and packaging.

Fluticus-OX Nasal Spray

Fluticus-OX Nasal Spray

Pack: 10ml (100 Metered Doses)

MRP: ₹499

View Fluticus-OX Nasal Spray →

Fluticasone Furoate (27.5 mcg) + Oxymetazoline (50 mcg) Nasal Spray is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Fluticasone Furoate (27.5 mcg) + Oxymetazoline (50 mcg) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.

Therapeutic Indications
  • Severe allergic rhinitis with prominent nasal obstruction
  • Acute exacerbation of perennial rhinitis
  • Short-term use to break the obstruction-cycle
  • Adjunct during initiation of steroid therapy
Mechanism of Action

Fluticasone Furoate suppresses the underlying eosinophilic inflammation via glucocorticoid receptor activation. Oxymetazoline is a selective alpha-1 / alpha-2A adrenergic agonist that constricts dilated nasal mucosal blood vessels, providing rapid (within 5–10 minutes) shrinkage of swollen turbinates and restoration of nasal patency.

Dosage & Administration
  • Adults: 1 spray in each nostril twice daily for not more than 7 days
  • Then continue plain fluticasone furoate spray for maintenance
  • Avoid prolonged use to prevent rebound rhinitis
  • Prime the bottle before first use
Side Effects
  • Nasal dryness or burning
  • Rebound nasal congestion with prolonged use
  • Mild palpitations occasionally
  • Epistaxis
Contraindications
  • Severe cardiovascular disease
  • Untreated narrow-angle glaucoma
  • Children under 12 years
  • Concurrent MAO inhibitors
  • Pregnancy and breastfeeding
Storage

Store below 25°C.

PCD Pharma Franchise for Fluticasone Furoate (27.5 mcg) + Oxymetazoline (50 mcg) Nasal Spray

  • ✓ WHO-GMP certified manufacturing facility
  • ✓ Pan-India monopoly distribution rights available
  • ✓ Multiple pack sizes: 10ml (100 Metered Doses)
  • ✓ Trade-friendly PTR / PTS margins
  • ✓ Free promotional material on request
  • ✓ Full DCGI documentation and quality certificates supplied

Trumac Healthcare offers 1 brand option for Fluticasone Furoate (27.5 mcg) + Oxymetazoline (50 mcg) Nasal Spray — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.

For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Fluticasone Furoate (27.5 mcg) + Oxymetazoline (50 mcg) Nasal Spray, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.

Frequently Asked Questions

Who is the manufacturer of Fluticasone Furoate (27.5 mcg) + Oxymetazoline (50 mcg) Nasal Spray?

Trumac Healthcare is a WHO-GMP certified manufacturer of Fluticasone Furoate (27.5 mcg) + Oxymetazoline (50 mcg) Nasal Spray in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.

Is Fluticasone Furoate (27.5 mcg) + Oxymetazoline (50 mcg) Nasal Spray available for PCD pharma franchise on monopoly basis?

Yes. We offer Fluticasone Furoate (27.5 mcg) + Oxymetazoline (50 mcg) Nasal Spray for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.

What pack sizes are available for Fluticasone Furoate (27.5 mcg) + Oxymetazoline (50 mcg) Nasal Spray?

Available pack sizes include: 10ml (100 Metered Doses).

What is the MRP / trade price for Fluticasone Furoate (27.5 mcg) + Oxymetazoline (50 mcg) Nasal Spray?

MRPs range from ₹499 to ₹499 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.

How do I place an order or franchise enquiry?

WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.

Ready to start your PCD franchise for Fluticasone Furoate (27.5 mcg) + Oxymetazoline (50 mcg) Nasal Spray?

Get Pricing & Franchise Terms →